Company Data
AN2 Therapeutics Inc.
Ticker
ANTX
Current Price
$1.22 -3.17%
Market Cap
$36.5M
Price Target
Refer to Report
Volume
83.5K
52wk Range
$0.87 - $21.55
Overview
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.